Dong Guo | Nanotechnology | Best Researcher Award

Dr. Dong Guo | Nanotechnology | Best Researcher Award

The Third Affiliated Hospital of Southern Medical University | China

Dr. Dong Guo is a dedicated and emerging scholar in the field of Orthopaedics, currently pursuing his Ph.D. at Southern Medical University under the guidance of Dr. Denghui Xie. With a solid background in clinical medicine, Dong Guo has quickly progressed through rigorous academic training and impactful research roles. He brings a multidisciplinary approach to medical science, integrating knowledge from cellular biology, nanotechnology, and regenerative medicine. His contributions have already begun to shape promising directions in rheumatoid arthritis and osteoarthritis treatment.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

Dong Guo demonstrates exceptional potential and performance in biomedical research, particularly in orthopaedics and inflammatory joint diseases such as rheumatoid arthritis, osteoarthritis, and osteoporosis. His strong educational foundation—holding a Bachelor in Clinical Medicine, a Master’s, and now pursuing a Ph.D. at Southern Medical University—provides a solid platform for advanced research. His research productivity is evident through multiple Q1 journal publications with high impact factors:

  • Bone Research (IF: 13.362, cited by 51)

  • Bioactive Materials (IF: 18.0)

  • Theranostics (IF: 12.4)

  • Journal of Nanobiotechnology (IF: 10.6)

🎓 Education

Dr. Dong Guo commenced his academic journey with a Bachelor’s degree in Clinical Medicine (2013–2018) from Jiangsu University, followed by a Master’s degree in Orthopaedics (2018–2021) under Dr. Daozhang Cai at Southern Medical University. He is currently enrolled as a Ph.D. candidate in Orthopaedics (2022–present) under the mentorship of Dr. Denghui Xie at the same institution, focusing on innovative therapies for chronic musculoskeletal disorders.

🏥 Experience

From July 2021 to September 2022, Dong Guo served as a Research Assistant at The Third Affiliated Hospital of Southern Medical University, where he actively contributed to experimental research and clinical translational work in orthopaedics and inflammatory diseases. His academic visibility was highlighted through oral presentations at prestigious national forums, including the Chinese Sport Medical Doctor Association (2021 & 2024) and the Guangdong Sport Medical Doctor Association (2022).

🔬 Research Interests On Nanotechnology

Dong Guo’s research is driven by a passion to decode the cellular and molecular mechanisms underlying joint diseases. His primary interests include Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, and Senescence, with focused work on osteoclast biology, mitochondrial biogenesis, and nanotherapeutic interventions. He is also exploring innovative delivery mechanisms for gene therapy in degenerative diseases.

🏆 Awards

Dong Guo has received several accolades for his scholarly excellence and research innovation:

  • National Scholarships in 2022 and 2024

  • Best Oral Presentation Award at the 1st BMEMat-Advanced Materials Joint Symposium (2024)

  • Selected Oral Presentation Award at the Guangdong-Hong Kong-Macao Greater Bay Area Orthopedic Postgraduate Academic Forum (2024)

  • Excellent Manuscript Award by the Chinese Sport Medical Doctor Association (2021)

  • Second Prize in Thesis Competition at the Guangdong Postgraduate Academic Forum (2023)

  • High-Quality Experimental Works recognition at Southern Medical University (2022)

📚 Publications

Dong Guo has published several high-impact research articles in prestigious journals:

  1. FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis, Bone Research, 2022. Cited by: 51

  2. A Nanoplatform Reprograms Hypoxia M1 Macrophage by Interrupting Adverse Feedback Loop for Synergistic Rheumatoid Arthritis Therapy, Bioactive Materials, 2024.

  3. Photoreceptor-targeted extracellular vesicles-mediated delivery of Cul7 siRNA for retinal degeneration therapy, Theranostics, 2024.

  4. Polypyrrole-ferric phosphate-methotrexate nanoparticles enhance apoptosis/ferroptosis of M1 macrophages via autophagy blockage for rheumatoid arthritis treatment, Journal of Nanobiotechnology, 2025.

  5. Rspo2 exacerbates rheumatoid arthritis by targeting aggressive phenotype of fibroblast-like synoviocytes and disrupting chondrocyte homeostasis via Wnt/β-catenin pathway, Arthritis Research & Therapy, 2023.

🧾 Conclusion

Dong Guo exemplifies the qualities of a rising star in biomedical and clinical research. His integrated expertise in orthopaedics, nanotherapy, and molecular signaling, paired with his recognized contributions to high-impact publications and presentations, make him a worthy nominee for any Best Researcher Award. With a promising trajectory and a passion for scientific discovery, Dong Guo is poised to lead innovative advancements in musculoskeletal disease therapy. 🌟

Haochen Yao | Nanotechnology | Best Researcher Award

Prof. Dr. Haochen Yao | Nanotechnology | Best Researcher Award

Dr. Haochen Yao is an accomplished Associate Professor affiliated with the Key Laboratory & Engineering Laboratory of Lymphatic Surgery of Jilin Province and the China-Japan Union Hospital at Jilin University. With a deep-rooted dedication to clinical innovation and translational research in lymphatic and vascular diseases, Dr. Yao has made significant contributions to biomedical science, particularly in immune modulation and nanomedicine. His career reflects a balance of academic excellence, clinical practice, and impactful scientific discovery.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. High-Impact Publications:
    Dr. Yao has an impressive publication record in top-tier journals such as Nano Letters, Advanced Science, ACS Applied Materials & Interfaces, and Biomaterials. Many of these journals have high impact factors (ranging from 6.2 to 14.3), indicating the significance and quality of his work.

  2. Cutting-Edge Research Areas:
    His research focuses on cancer immunotherapy, nanomedicine, biomaterials, and tumor microenvironment modulation—fields that are both clinically relevant and technologically advanced. These areas have significant translational potential, especially for oncology and regenerative medicine.

  3. Innovative Techniques:
    Dr. Yao utilizes advanced methodologies, including nano-drug delivery, immune checkpoint enhancement, and hydrogel-based wound healing, showcasing technical innovation.

  4. Multidisciplinary Collaboration:
    His affiliations with engineering laboratories and joint research centers demonstrate strong interdisciplinary collaboration, essential for translational biomedical research.

  5. Leadership and Recognition:
    As an associate professor and corresponding or first author on several papers, Dr. Yao has shown leadership in his research teams. He also works in recognized institutions like Jilin University and the Chinese Academy of Sciences.

🎓 Education

Dr. Yao earned all his academic degrees from Jilin University, reflecting a profound and continuous commitment to medical science. He completed his Ph.D. in Pathogenic Biology (2019–2022), preceded by a Master’s degree in Surgery (2015–2018), and a Bachelor’s degree in Clinical Medicine (2009–2014). This progressive academic pathway underscores his solid foundation in both theoretical knowledge and clinical skills.

💼 Experience

Currently serving as an Attending Physician at the General Surgery Center of the First Hospital of Jilin University (2022.09–2025.03), Dr. Yao combines medical practice with cutting-edge research. He previously contributed as a Research Assistant at the Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences (2019.09–2022.06), where he cultivated his expertise in polymeric biomaterials and nano-based therapeutic systems.

🔬 Research Interest On Nanotechnology

Dr. Yao’s research interests span nanomedicine, tumor immunotherapy, lymphatic system diseases, and biomaterials. His work is particularly focused on enhancing immune checkpoint therapies, modulating gut microbiota for cancer treatment, and designing multifunctional nanoprodrugs. He is passionate about integrating materials science with clinical oncology to develop next-generation therapeutics.

🏆 Awards

While specific awards are not listed in the provided CV, Dr. Yao’s consistent authorship in high-impact journals and his progressive academic and professional roles indicate recognition and respect in his field. This nomination itself stands as a testament to his outstanding contributions and potential.

📚 Publications

Dr. Yao has authored numerous impactful publications in leading journals. Below is a selection of his peer-reviewed work:

1. A Syringeable Immunotherapeutic Hydrogel Enhances T Cell Immunity via In-Situ Activation of STING Pathway for Advanced Breast Cancer Postoperative Therapy

  • Authors: Baozhen Zhang, Min Li, Jiahua Ji, Xinghui Si, Xiaojiao Yin, Guofeng Ji, Liqun Ren, Haochen Yao

  • Year: 2025

  • Journal: Frontiers in Immunology

  • DOI: 10.3389/fimmu.2025.1523436

2. An Antibacterial Hemostasis Sponge of Gelatin/Îľ-Poly-L-Lysine Composite

  • Authors: Yifan Lu, Xiangxin Lou, Wenxin Wang, Ziting Yang, Haochen Yao, Jinglei Wu

  • Year: 2025

  • Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials

  • DOI: 10.1002/jbm.b.35528

3. Chitosan-Based Immunomodulatory Bioadhesive Hydrogel Promotes Liver Hemostasis and Repair

  • Authors: Wenxin Wang, Haochen Yao, Jie Xia, Xinjian Wan, Jinglei Wu

  • Year: 2025

  • Journal: Carbohydrate Polymers

  • DOI: 10.1016/j.carbpol.2025.123268

4. In-Situ Activation of Biomimetic Single-Site Bioorthogonal Nanozyme for Tumor-Specific Combination Therapy

5. Synergistic Design of Hierarchical and Heterostructural P-NiMoO₄@Net-like Ni₂P for Enhanced Hydrogen Evolution Electrocatalysis

  • Authors: Jian Tang, Jun Fang, Haochen Yao, Jianglong Wei, Geng Gao, Yusong Yang, Bin Yang, Yaochun Yao

  • Year: 2025

  • Journal: Journal of Colloid and Interface Science

  • DOI: 10.1016/j.jcis.2025.137313

6. High‐Efficiency Carriers’ Separation Strategy Based Ultrasmall‐Bandgap CuWO₄ Sono‐Enhances GSH Antagonism for Cuproptosis Cascade Immunotherapy

  • Authors: Lichao Zhu, Zhisheng Guo, Yu Luo, Haiyan Huang, Kexin Zhang, Bingbing Duan, Renmiao Peng, Haochen Yao, Chao Liang, Kaiyang Wang

  • Year: 2025

  • Journal: Advanced Science

  • DOI: 10.1002/advs.202500576

7. Myocardia‐Injected Synergistically Anti‐Apoptotic and Anti‐Inflammatory Poly(amino acid) Hydrogel Relieves Ischemia‐Reperfusion Injury

  • Authors: Qiang Luo, Zhibo Li, Wei Sun, Guoliang Wang, Haochen Yao, Guoqing Wang, Bin Liu, Jianxun Ding

  • Year: 2025

  • Journal: Advanced Materials

  • DOI: 10.1002/adma.202420171

8. A Tumor-Targeting Nano-Adjuvant for In Situ Vaccine Based on Ultrasound Therapy

  • Authors: Linjie Cui, Haochen Yao, Fuxin Xue, Jiali Sun, Xitong Ren, Mengfei Zheng, Zhilin Liu, Zhaohui Tang

  • Year: 2024

  • Journal: Aggregate

  • DOI: 10.1002/agt2.504

📝 Conclusion

Dr. Haochen Yao represents the future of translational biomedical research. His multidisciplinary approach, spanning surgery, nanotechnology, and immunology, exemplifies innovation with clinical relevance. His trajectory from clinical medicine to high-impact scientific contribution makes him a compelling candidate for this award nomination. 🌟